DOW JONES22,361.34+724.56 3.35%
S&P 5002,630.72+89.25 3.51%
NASDAQ7,774.15+271.77 3.62%

Piper Sandler Downgrades Inovio Pharmaceuticals to Neutral, Announces $8 Price Target

Piper Sandler analyst Christopher Raymond downgrades Inovio Pharmaceuticals (NASDAQ:INO) from Overweight to Neutral and announces $8 price target.

Benzinga · 03/13/2020 09:33

Piper Sandler analyst Christopher Raymond downgrades Inovio Pharmaceuticals (NASDAQ:INO) from Overweight to Neutral and announces $8 price target.